Revised guidelines for cardiovascular risk management - Time to stopmedication? A practice-based intervention study

British Journal of General Practice

Volumn 61, Issue 587, 2011, Pages

  Van Duijn, Huug J ^a   Belo, Janneke N ^a,b   Blom, Jeanet W ^c   Velberg, Irvine D ^a   Assendelft, Willem J J ^c  

^a Health Cooperative Katwijk Langs de Rijn ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

General practice; Guidelines; Hypercholesterolaemia; Hypertension; Primary care; Primary prevention

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RETREATMENT; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT FAILURE;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; CARDIOVASCULAR DISEASES; DECISION MAKING; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PRACTICE GUIDELINES AS TOPIC; RISK MANAGEMENT; UNNECESSARY PROCEDURES;

EID: 80053192300     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: 10.3399/bjgp11X578025     Document Type: Article

References (17)

1. Kannel WB, Brand N, Skinner JJ, et al. The relation of adiposity to blood pressure and development of hypertension. The Framinghamstudy. Ann Intern Med 1967; 67(1): 48-59.
2. Keys A, Aravanis C, Blackburn H, et al. Probability ofmiddle-agedmen developing coronary heart disease in five years. Circulation 1972; 45(4): 815-828.
3. Murray CJ, Lauer JA, Hutubessy RC, et al. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk. Lancet 2003; 361(9359): 717-725. (Pubitemid 36293625)
4. Kok L, Engelfriet P, Jacobs-van der Bruggen MA, et al. The cost-effectiveness of implementing a new guideline for cardiovascular riskmanagement in primary care in the Netherlands. Eur J Cardiovasc Prev Rehabil 2009; 16(3): 371-376.
5. Grover S, Coupal L, Lowensteyn I. Preventing cardiovascular disease among Canadians: Is the treatment of hypertension or dyslipidemia cost-effective? Can J Cardiol 2008; 24(12): 891-898.
6. Burgers JS, Simoons ML, Hoes AW, et al. Cardiovasculair risicomanagement. [Guideline 'Cardiovascular riskmanagement'; in Dutch].Ned Tijdschr Geneeskd 2007; 151(19): 1068-1074.
7. Conroy RM, Pyorala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24(11): 987-1003. (Pubitemid 36712275)
8. Espeland MA,Whelton PK, Kostis JB, et al. Predictors andmediators of successful long-termwithdrawal fromantihypertensivemedications. Trial of nonpharamcologic intervention in the elderly. Arch FamMed 1999; 8(3): 228-236.
9. Aylett M, Creighton P, Jachuck S, et al. Stopping drug treatment of hypertension: experience in 18 British general practices. Br J Gen Pract 1999; 49(449): 977-980. (Pubitemid 30003947)
10. Charalabopoulos K, Charalabopoulos A, Papalimneou V, et al. Consequences of the discontinuation of antihypertensive treatment in successfully treated patients. Int J Clin Pract 2005; 59(6): 704-708. (Pubitemid 44192641)
11. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical classification system. http://www.whocc.no/atc/ (accessed 24 Mar 2011).
12. Wonca International Classification Committee. The International Classification of Primary Care. http://www.globalfamilydoctor.com/wicc/ icpcstory.html (accessed 24 Mar 2011).
13. Walma E, van Dooren C, Prins A, et al. Withdrawal of long-termdiuretic medication in elderly patients: a double-blind randomised trial.BMJ 1997; 315(7106): 464-468. (Pubitemid 27348471)
14. Nelson M, Reid C, KrumH, McNeil J. A systematic review of predictors of maintenance after withdrawal of antihypertensive drugs. AmJ Hypertens 2001; 14(2): 98-105. (Pubitemid 32171560)
15. van der Linden MW,Westert GP, De Bakker DH, et al. Tweede nationale studie naar ziekten en verrichtingen in de huisartsenpraktijk: klachten en aandoeningen in de bevolking en in de huisartspraktijk. [Second national survey onmorbidity and interventions in general practice: complaints and diseases in the population and in general practice]. Utrecht/Bilthoven: Nivel/RIVM, 2004.
16. van de Lisdonk EH, van de Bosch WJHM, Huygen FJA, Lagro-Janssen ALM. Ziekten in de huisartspraktijk [Illnesses in general practice; in Dutch]. Maarssen: Elsevier/Bunge, 1999.
17. Schelleman H, Klungel OH, Kromhout D, et al. Prevalence and determinants of undertreatment of hypertension in the Netherlands. J HumHypertens 2004; 18(5): 317-324. (Pubitemid 38660178)